Form 57.123 Antimicrobial Use and Resistance (AUR): Microbiology Lab

[NCEZID] The National Healthcare Safety Network (NHSN)

57.123 (AUR)-Microbiology Data Electronic Upload Specification Tables-Clean Version

57.123 Antimicrobial Use and Resistance (AUR) - Microbiology Data Upload Tables

OMB: 0920-0666

Document [docx]
Download: docx | pdf

Form Approved

OMB No. 0920-0666

Exp. Date: 12/31/2026

www.cdc.gov/nhsn

Antimicrobial Use and Resistance (AUR): Microbiology Laboratory Data

Monthly Electronic Upload Specification Tables

These data will be collected in an aggregate monthly electronic file transfer from the facility to NHSN via Clinical Document Architecture (CDA).

Page 1 of 2

Table 1. CDA File Descriptors

These data elements will be transmitted with each month’s report.

Variable Name

Description of Variable

orgid

NHSN Facility ID number

location

NHSN location code

month

Denominator month

year

Denominator year

Application OID

Vendor software ID number

SDS validation ID

ID provided by NHSN Team confirming vendor software passed validation

Table 2. Isolate Event Details

These data elements will be transmitted with each month’s report.

Variable Name

Description of Variable

Examples

eventID

Event ID number


specimenDate

Date specimen collected


specimenSource

Specimen Source

Blood, lower respiratory, urine, cerebral spinal fluid, skin, soft tissue, wound, musculoskeletal




isolateID

Isolate identifier


facilityAdmitDate

Date admitted to facility


admitStatus

Was patient admitted to an inpatient location

Y/N

specimenLoc

Location of specimen collection


pathogen

Identified pathogen


PtDOB

Patient date of birth


PtGender

Patient gender


PtID

Patient ID number


PtRace

Patient race

Select all that apply):

American Indian or Alaska Native

Asian

Black or African American

Middle Eastern or North African

Native Hawaiian or Pacific Islander

White

Unknown

Declined to respond


PtEthnicity

Patient ethnicity

Hispanic or Latino

Not Hispanic or Latino

Unknown

Declined to respond


PtSexatBirth

Patient sex at birth F M Unknown


PtGenderIdentity

Patient gender identity

Male

Female

Male-to-female transgender

Female-to-male transgender

Identifies as non-conforming

Other

Asked but unknown


PtLanguage

Patient language


PtInterpreterNeeded

Patient interpreter needed


PtInterpreterUsed

Patient interpreter used


Table 2a. List of Eligible Pathogens

This is the list of pathogens that will be accepted into NHSN as part of the antimicrobial resistance reporting. Complete list of accepted is found in the NHSN IDM Workbook.

Acinetobacter species


Morganella morganii

Candida species


Proteus species


Enterobacter species



Enterococcus faecalis



Enterococcus faecium

Pseudomonas aeruginosa


Enterococcus species

Serratia marcescens

Citrobacter species

Escherichia coli

Staphylococcus aureus


Klebsiella species

Stenotrophomonas maltophilia



Streptococcus agalactiae



Streptococcus pneumoniae



Streptococcus pyogenes

Assurance of Confidentiality:  The voluntarily provided information obtained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not otherwise be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306 and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)).


Public reporting burden of this collection of information is estimated to average 5 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering, and maintaining the data needed, and completing and reviewing the collection of information.  An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number.  Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, Reports Clearance Officer, 1600 Clifton Rd., MS H21-8, Atlanta, GA 30333, ATTN:  PRA (0920-0666).

CDC 57.123 v10, 13.0



Antimicrobial Use and Resistance (AUR): Microbiology Laboratory Data

Monthly Electronic Upload Specification Tables


Page 2 of 2

Table 3. Antimicrobial Susceptibility Details

These data elements will be transmitted with each month’s report.

Variable Name

Description of Variable

Examples

drug test

Antimicrobial used for susceptibility test


PBP2a-agglutination

PBP2a-agglutination


PCRmec-gene

PCR mec-gene


EtestSign

Etest sign

>, <, =

EtestValue

Etest value


EtestInterp

Interpretation of Etest


MICsign

MIC sign


MICinterp

Interpretation of the MIC test


MICvalue

MIC value


ZoneSign

Zone sign


ZoneInterp

Interpretation of zone test


ZoneValue

Zone value


MolecularTest

Rapid molecular detection of antimicrobial resistance markers


MolecularTestResult

Result of rapid molecular detection of antimicrobial resistance markers test


FinIntrep

Final interpretation result


Table 3a. List of Antimicrobials used for Susceptibility Testing

This is the list of antimicrobials that will be accepted into NHSN as part of the antimicrobial resistance reporting.

Amikacin

Cefoxitin


Meropenem

Rezafungin

Amoxicillin

Ceftaroline

Doxycycline

Meropenem-vaborbactam

Rifampin

Amoxicillin-clavulanic acid

Ceftazidime

Ertapenem

Micafungin

Streptomycin

Amphotericin B

Ceftazidime/Avibactam

Erythromycin

Minocycline

Streptomycin – high level

Ampicillin

Ceftibuten

Fluconazole

Moxifloxacin

Sulbactam/Durlobactam

Ampicillin-sulbactam

Ceftolozane/Tazobactam

Fosfomycin

Nitrofurantoin


Anidulafungin

Ceftriaxone


Oritavancin

Tedizolid

Azithromycin

Cefuroxime

Gentamicin

Oxacillin

Telavancin

Aztreonam


Gentamicin – high level

Penicillin G

Tetracycline

Caspofungin

Ciprofloxacin

Imipenem-cilastatin

Penicillin V


Cefazolin

Clarithromycin

Imipenem-relebactam with cilastatin

Piperacillin-tazobactam

Trimethoprim-sulfamethoxazole

Cefepime

Clindamycin

Lefamulin

Plazomicin

Vancomycin

Cefiderocol

Colistin

Levofloxacin

Polymyxin B

Voriconazole

Cefotaxime

Dalbavancin

Linezolid

Posaconazole


Cefotetan

Daptomycin




Table 4. Denominator Data

These data elements will be transmitted with each month’s report.

Variable Name

Description of Variable

numAdmissions

Number of admissions

numPtDays

Number of inpatient days

numEncounters

Number of outpatient encounters

noAREvent

No AR Events were identified



File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleAUR: Microbiology Laboratory Data
AuthorCDC/NCEZID/DHQP
File Modified0000-00-00
File Created2024-11-16

© 2024 OMB.report | Privacy Policy